Advaxis Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include KemPharm.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. | |
Founding Date | Founding Date 2018 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US |
Employees | Employees 888% decrease | Employees 333% increase |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) 200.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $106.5m (FY, 2025) |
Net income | Net income ($12.2m) (FY, 2025) | Net income $83.2m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
KemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View company